Seroprevalence of HBV infection and its risk factors in the west of iran: A population-based study

International Journal of Preventive Medicine

Volumn 3, Issue 11, 2012, Pages 770-775

  Alavian, Seyed Moayed ^a   Tabatabaei, Seyed Vahid ^b   Ghadimi, Teyyeb ^c   Beedrapour, Farzam ^c   Kafi Abad, Sedigheh Amini ^d   Gharehbaghian, Ahmad ^d   Abolghasemi, Hassan ^d  

^a Baqiyatallah Medical Sciences University Baqyatallah Hospital   (Iran)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Epidemiology; Hepatitis; Iran; Prevalence; Virus

Indexed keywords

HEPATITIS ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS D ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CHILD; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; INFECTION RISK; IRAN; MALE; MARRIAGE; PRESCHOOL CHILD; RISK ASSESSMENT; SEROPREVALENCE; VIRUS CARRIER; VIRUS TRANSMISSION;

EID: 84871634386     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: A global overview. Clin Liver Dis 2010;14:1-21, vii.
2. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 2007;16:403-6.
3. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med 2000;2:192-201.
4. Lankarani KB, Froozi MS, Nabipoor I, Fattahi F, Sarafrazyazdi M, Malekzadeh R, et al. Reassessment of the role of hepatitis B and C viruses in postnecrotic cirrhosis and chronic hepatitis in southern Iran. Irn J Med Sci 1999;24:117-21.
5. Shamszad M, Farzadegan H. related cirrhosis and hepatocellular carcinoma in Iran. Journal of Iranian Medical Council 1982;8:228.
6. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population: A viral marker study. Ann Acad Med Singapore 1980;9:144-8.
7. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran. Journal of Iranian Medical Council. 1997;15 (2):183-200.
8. Toukan AU. Control of hepatitis B in the Middle East. In: Rizetto M, Purcell RH, Gerin JL, Verme G, editors. Viral Hepatitis and Liver Diseases. 1 st ed. Turin: Minerva Media; 1997. p. 678-80.
9. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: A population based study. J Trop Med Hyg 1993;96:277-87.
10. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J 2000;6:1114-6.
11. Alizadeh AH, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J 2006;12:528-37.
12. Khedmat H, Alavian SM, Miri SM, Amini M, Abolghasemi H, Hajibeigi B, et al. Trends in seroprevalence of hepatitis B, hepatitis C, HIV, and syphilis infections in Iranian blood donors from 2003 to 2005. Hepat Mon 2009;9:24-8.
13. Nokhodian Z, Kassaian N, Ataei B, Javadi AA, Shoaei P, Farajzadegan Z, et al. Hepatitis B markers in Isfahan, Central Iran: A Population-Based Study. Hepat Mon 2009;9:12-6.
14. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B prevalence and risk factors in blood donors in Ghazvin, IR, Iran. Hepat Mon 2005;5:117-22.
15. Adibi P, Ghassemian R, Alavian SM, Ranjbar M, Mohammadalizadeh AH, Nematizadeh F, et al. Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers. Saudi Med J 2004;25:1414-8.
16. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res 2006;36:265-71.
17. Alavian SM, Hajariazdeh B, Ahmadzad Asl M, Kabir A, Bagheri Lankarani K. Hepatitis B virus infection in Iran: A systematic review. Hepat Mon 2008;8:281-94.
18. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon 2011;11:19-22.
19. Sali SH, Bashtar R, Alavian SM. Risk factors in chronic hepatitis B infection: A case-control study. Hepat Mon 2005;5:109-15.
20. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994;23:437-55.
21. Ioannou GN. Hepatitis B virus in the United States: Infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 2011;154:319-28.